Understand the source comparison
Clinical Evidence: Finasteride vs AHK-Cu Efficacy
Finasteride has the strongest clinical evidence base of any non-surgical hair loss treatment. The pivotal Phase III trials published in the Journal of the American Academy of Dermatology followed 1,553 men aged 18–41 for five years. At two years, 83% of finast
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Finasteride has the strongest clinical evidence base of any non-surgical hair loss treatment. The pivotal Phase III trials published in the Journal of the American Academy of Dermatology followed 1,553 men aged 18–41 for five years. At two years, 83% of finasteride users maintained or increased hair count versus 28% of placebo. A clinically meaningful difference. By year five, 48% showed visible hair regrowth on vertex assessment. The Norwood-Hamilton scale improvements were modest but consistent: most men stopped losing hair rather than reversing loss.
- AHK-Cu lacks equivalent large-scale human trials. The supporting evidence comes from in vitro studies, small observational cohorts, and mechanistic research. A 2015 study in Skin Pharmacology and Physiology tested copper peptides on cultured dermal papilla cells and found significant upregulation of hair growth genes (VEGF, IGF-1) and downregulation of TGF-β1, a fibrosis marker associated with scarring alopecia. A 24-week observational study of 30 participants using 0.05% topical AHK-Cu reported subjective improvement in hair thickness and density in 60% of users. But this was not placebo-controlled, and the assessment method was dermatologist evaluation rather than standardized hair counts.
- Our team has found that peptide-based treatments show the most promise when combined with established therapies like minoxidil rather than used as standalone alternatives. Real Peptides offers research-grade copper peptides that meet the purity standards required for laboratory investigation. The same precision that allows researchers to isolate peptide effects from formulation variables.